Hepatocellular Carcinoma Drugs (PD-1/PD-L1 Inhibitors, Tyrosine Kinase Inhibitors) Industry Report 2024: A $1.62 Billion Market Opportunity by 2028
24 janv. 2024 13h42 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global hepatocellular...
Hepatocellular Carcinoma Clinical Trial Analysis: DelveInsight Evaluates a Robust Pipeline as 90+ Influential Pharma Players to Set Foot in the Domain
26 juin 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, June 26, 2023 (GLOBE NEWSWIRE) -- Hepatocellular Carcinoma Clinical Trial Analysis: DelveInsight Evaluates a Robust Pipeline as 90+ Influential Pharma Players to Set Foot in the...
Hepatocellular Carcinoma Drugs Market is Forecasted to Reach Nearly USD 1.95 Billion by 2030, Size, Share, Trends, Competitive Scenario and Regional Analysis
11 janv. 2023 21h30 HE
|
Data Bridge Market Research
SYDNEY, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research Published Latest Hepatocellular Carcinoma Drugs Market Study with an in-depth analysis of the current scenario, the Market size,...